Wallerian Degeneration

Wallerian degeneration refers to axonal degeneration in response to nerve fiber damage, where the axon distal to the injury site degenerates. Here is the latest research on Wallerian degeneration.

August 28, 2020
Open Access

Closing the Gap Between Mammalian and Invertebrate Peripheral Nerve Injury: Protocol for a Novel Nerve Repair

JMIR Research Protocols
Maxwell VestAshley Pistorio
January 13, 2021
Open Access

Changes in proteins related to early nerve repair in a rat model of sciatic nerve injury

Neural Regeneration Research
Yu-Song YuanYu-Hui Kou
December 23, 2020
Open Access

Oligodendrocytes support axonal transport and maintenance via exosome secretion

PLoS Biology
Carsten FrühbeisEva-Maria Krämer-Albers
November 20, 2020
Open Access

In vivo imaging of injured cortical axons reveals a rapid onset form of Wallerian degeneration

BMC Biology
Alison Jane CantyVincenzo De Paola
December 10, 2020

Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia

Neuron
Jiun-Min HsuMarc R Freeman
December 4, 2020
Review
Open Access

Hedging against Neuropathic Pain: Role of Hedgehog Signaling in Pathological Nerve Healing

International Journal of Molecular Sciences
Nathan Moreau, Yves Boucher
November 25, 2020
Open Access

Emergence of the Wallerian degeneration pathway as a mechanism of secondary brain injury

Neural Regeneration Research
Ciaran Scott Hill, Andrea Loreto
December 16, 2020
Open Access

Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation

Scientific Reports
Aysel Cetinkaya-FisginAhmet Höke
August 24, 2020

Identification of the first noncompetitive SARM1 inhibitors

Bioorganic & Medicinal Chemistry
H. S. LoringPaul Thompson
December 1, 2020

Clinical Features, Risk Factors, and Early Prognosis for Wallerian Degeneration in the Descending Pyramidal Tract after Acute Cerebral Infarction

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Xiaolu ZhengSipei Pan
December 4, 2020
Open Access

Ascorbic acid accelerates Wallerian degeneration after peripheral nerve injury

Neural Regeneration Research
Lixia LiJiasong Guo
August 29, 2020
Preprint
Open Access

A Liquid-to-Solid Phase Transition Enhances the Catalytic Activity of SARM1

BioRxiv : the Preprint Server for Biology
H. S. Loring, Paul Thompson
October 4, 2020
Open Access

Coding transcriptome analyses reveal altered functions underlying immunotolerance of PEG-fused rat sciatic nerve allografts

Journal of Neuroinflammation
Tyler A SmithGeorge D Bittner
September 24, 2020
Open Access

Regulation of degenerative spheroids after injury

Scientific Reports
Yu YongChristopher Deppmann
December 7, 2020
Preprint
Open Access

Tau-mediated axonal degeneration is prevented by activation of the WldS pathway

BioRxiv : the Preprint Server for Biology
K. StubbsAmrit Mudher
September 15, 2020
Open Access

Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma

Clinical Medicine Insights. Oncology
Li LiYong He

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/wallerian-degeneration/e19b5f59-2a1b-4351-9d92-6c8f9e22c35e